X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Merck Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs MERCK LTD - Comparison Results

MERCK LTD 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE MERCK LTD TTK HEALTHCARE/
MERCK LTD
 
P/E (TTM) x 30.1 26.4 113.9% View Chart
P/BV x 5.5 3.0 187.4% View Chart
Dividend Yield % 0.5 1.0 54.8%  

Financials

 TTK HEALTHCARE   MERCK LTD
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
MERCK LTD
Dec-16
TTK HEALTHCARE/
MERCK LTD
5-Yr Chart
Click to enlarge
High Rs6631,060 62.6%   
Low Rs399623 64.0%   
Sales per share (Unadj.) Rs535.6632.4 84.7%  
Earnings per share (Unadj.) Rs15.945.7 34.9%  
Cash flow per share (Unadj.) Rs20.062.3 32.1%  
Dividends per share (Unadj.) Rs4.0011.00 36.4%  
Dividend yield (eoy) %0.81.3 57.6%  
Book value per share (Unadj.) Rs137.6388.8 35.4%  
Shares outstanding (eoy) m7.7716.60 46.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.01.3 74.5%   
Avg P/E ratio x33.318.4 181.0%  
P/CF ratio (eoy) x26.513.5 196.4%  
Price / Book Value ratio x3.92.2 178.4%  
Dividend payout %25.124.1 104.3%   
Avg Mkt Cap Rs m4,12713,969 29.5%   
No. of employees `0001.71.6 107.9%   
Total wages/salary Rs m6071,487 40.8%   
Avg. sales/employee Rs Th2,436.76,631.9 36.7%   
Avg. wages/employee Rs Th355.2939.2 37.8%   
Avg. net profit/employee Rs Th72.5479.4 15.1%   
INCOME DATA
Net Sales Rs m4,16210,498 39.6%  
Other income Rs m61242 25.2%   
Total revenues Rs m4,22310,741 39.3%   
Gross profit Rs m1971,135 17.4%  
Depreciation Rs m32276 11.5%   
Interest Rs m300-   
Profit before tax Rs m1971,102 17.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m73343 21.2%   
Profit after tax Rs m124759 16.3%  
Gross profit margin %4.710.8 43.8%  
Effective tax rate %37.031.1 118.8%   
Net profit margin %3.07.2 41.2%  
BALANCE SHEET DATA
Current assets Rs m1,6296,410 25.4%   
Current liabilities Rs m1,0588,828 12.0%   
Net working cap to sales %13.7-23.0 -59.5%  
Current ratio x1.50.7 212.1%  
Inventory Days Days3058 51.6%  
Debtors Days Days3438 87.5%  
Net fixed assets Rs m5561,406 39.6%   
Share capital Rs m78166 46.8%   
"Free" reserves Rs m8786,286 14.0%   
Net worth Rs m1,0696,455 16.6%   
Long term debt Rs m1590-   
Total assets Rs m2,3998,828 27.2%  
Interest coverage x7.6NM-  
Debt to equity ratio x0.10-  
Sales to assets ratio x1.71.2 145.9%   
Return on assets %6.48.6 74.6%  
Return on equity %11.611.8 98.5%  
Return on capital %18.517.1 108.1%  
Exports to sales %0.88.3 9.5%   
Imports to sales %1.421.0 6.7%   
Exports (fob) Rs m33869 3.8%   
Imports (cif) Rs m582,209 2.6%   
Fx inflow Rs m33959 3.4%   
Fx outflow Rs m632,612 2.4%   
Net fx Rs m-30-1,653 1.8%   
CASH FLOW
From Operations Rs m1271,070 11.8%  
From Investments Rs m-146-750 19.5%  
From Financial Activity Rs m22-150 -14.6%  
Net Cashflow Rs m3171 1.5%  

Share Holding

Indian Promoters % 65.4 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 3.7 18.2 20.3%  
FIIs % 5.2 1.0 520.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 29.1 88.7%  
Shareholders   12,723 28,591 44.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   IPCA LABS  SANOFI INDIA  ALEMBIC PHARMA  ORCHID PHARMA LTD  NOVARTIS  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Post Noon Sell-Off; Infosys Falls 5.4%(Closing)

Share markets in India witnessed a sharp fall in the final minutes of trade. At the closing bell, the BSE Sensex closed lower by 266 points. While, the NSE Nifty finished lower by 83 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Aug 21, 2017 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS